Harald J. Maier

1.5k total citations
27 papers, 1.1k citations indexed

About

Harald J. Maier is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Harald J. Maier has authored 27 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 14 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Harald J. Maier's work include NF-κB Signaling Pathways (8 papers), FOXO transcription factor regulation (6 papers) and CAR-T cell therapy research (5 papers). Harald J. Maier is often cited by papers focused on NF-κB Signaling Pathways (8 papers), FOXO transcription factor regulation (6 papers) and CAR-T cell therapy research (5 papers). Harald J. Maier collaborates with scholars based in Germany, United States and Switzerland. Harald J. Maier's co-authors include Thomas Wirth, Hartmut Beug, Tobias G. Schips, U. Schmidt, Margit A. Huber, Thomas Braun, Astrid Wietelmann, Bernd Baumann, Alexey Ushmorov and Thomas Boettger and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Harald J. Maier

25 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harald J. Maier Germany 16 613 333 280 191 130 27 1.1k
Liwen Li China 22 669 1.1× 255 0.8× 220 0.8× 216 1.1× 53 0.4× 58 1.2k
Xiaoqian Qian China 8 503 0.8× 192 0.6× 215 0.8× 214 1.1× 68 0.5× 12 913
Yuyu Yang China 25 888 1.4× 168 0.5× 235 0.8× 210 1.1× 107 0.8× 45 1.3k
Keyvan Mahboubi United States 15 700 1.1× 284 0.9× 173 0.6× 331 1.7× 205 1.6× 22 1.3k
А. И. Карселадзе Russia 14 436 0.7× 205 0.6× 296 1.1× 136 0.7× 80 0.6× 46 1.0k
Yunhe Liu China 19 438 0.7× 246 0.7× 164 0.6× 167 0.9× 345 2.7× 51 1.1k
Marie‐Claude Beauchamp Canada 18 779 1.3× 386 1.2× 229 0.8× 101 0.5× 70 0.5× 28 1.2k

Countries citing papers authored by Harald J. Maier

Since Specialization
Citations

This map shows the geographic impact of Harald J. Maier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harald J. Maier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harald J. Maier more than expected).

Fields of papers citing papers by Harald J. Maier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harald J. Maier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harald J. Maier. The network helps show where Harald J. Maier may publish in the future.

Co-authorship network of co-authors of Harald J. Maier

This figure shows the co-authorship network connecting the top 25 collaborators of Harald J. Maier. A scholar is included among the top collaborators of Harald J. Maier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harald J. Maier. Harald J. Maier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weissinger, Stephanie E., et al.. (2024). NEMO/NF-κB signaling functions as a double-edged sword in PanIN formation versus progression to pancreatic cancer. Molecular Cancer. 23(1). 103–103. 4 indexed citations
2.
Landsburg, Daniel J., Amy Moskop, S.R. Foley, et al.. (2024). Durable Efficacy and Manageable Safety in Patients Age ≥75 Years with Relapsed/Refractory Large B-Cell Lymphoma Treated with Tisagenlecleucel in the Real-World Setting. Transplantation and Cellular Therapy. 30(2). S187–S188.
3.
Landsburg, Daniel J., Amy Moskop, S.R. Foley, et al.. (2023). Durable Efficacy and Manageable Safety in Patients Age ≥ 75 Years with Relapsed/Refractory Large B-Cell Lymphoma Treated with Tisagenlecleucel in the Real-World Setting. Blood. 142(Supplement 1). 3496–3496. 2 indexed citations
4.
Steiger, Katja, et al.. (2021). Deletion of NEMO Inhibits EMT and Reduces Metastasis in KPC Mice. Cancers. 13(18). 4541–4541. 4 indexed citations
6.
Katz, Sarah–Fee, Medhanie Mulaw, Harald J. Maier, et al.. (2019). An IKK/NF-κB Activation/p53 Deletion Sequence Drives Liver Carcinogenesis and Tumor Differentiation. Cancers. 11(10). 1410–1410. 5 indexed citations
7.
Meyer, Patrick E., Pallab Maity, Andreas Burkovski, et al.. (2017). A model of the onset of the senescence associated secretory phenotype after DNA damage induced senescence. PLoS Computational Biology. 13(12). e1005741–e1005741. 58 indexed citations
8.
Konukiewitz, Björn, et al.. (2016). Epithelial NEMO/IKKγ limits fibrosis and promotes regeneration during pancreatitis. Gut. 66(11). 1995–2007. 18 indexed citations
9.
Papathanasiou, Stamatis, Steffen Rickelt, María Eugenia Soriano, et al.. (2015). Tumor necrosis factor-α confers cardioprotection through ectopic expression of keratins K8 and K18. Nature Medicine. 21(9). 1076–1084. 82 indexed citations
10.
Maier, Harald J., Katja Fiedler, Thomas Boettger, et al.. (2015). Cardiac-Specific Activation of IKK2 Leads to Defects in Heart Development and Embryonic Lethality. PLoS ONE. 10(11). e0141591–e0141591. 8 indexed citations
11.
Vogel, Marion, Linka Xie, Hanfeng Guan, et al.. (2014). FOXO1 repression contributes to block of plasma cell differentiation in classical Hodgkin lymphoma. Blood. 124(20). 3118–3129. 32 indexed citations
12.
Maier, Harald J., Martin Wagner, Tobias G. Schips, et al.. (2012). Requirement of NEMO/IKKγ for effective expansion of KRAS-induced precancerous lesions in the pancreas. Oncogene. 32(21). 2690–2695. 25 indexed citations
13.
Xie, Linka, Alexey Ushmorov, Frank Leithäuser, et al.. (2012). FOXO1 is a tumor suppressor in classical Hodgkin lymphoma. Blood. 119(15). 3503–3511. 141 indexed citations
14.
Schips, Tobias G., Astrid Wietelmann, Katharina Höhn, et al.. (2011). FoxO3 induces reversible cardiac atrophy and autophagy in a transgenic mouse model. Cardiovascular Research. 91(4). 587–597. 100 indexed citations
15.
Maier, Harald J., et al.. (2010). NF-κB promotes epithelial–mesenchymal transition, migration and invasion of pancreatic carcinoma cells. Cancer Letters. 295(2). 214–228. 180 indexed citations
16.
Maier, Harald J., Thomas Wirth, & Hartmut Beug. (2010). Epithelial-Mesenchymal Transition in Pancreatic Carcinoma. Cancers. 2(4). 2058–2083. 56 indexed citations
17.
Maier, Harald J.. (2003). Requirements for selective recruitment of Ets proteins and activation of mb-1/Ig-  gene transcription by Pax-5 (BSAP). Nucleic Acids Research. 31(19). 5483–5489. 29 indexed citations
18.
Maier, Harald J., Ralf Marienfeld, Thomas Wirth, & Bernd Baumann. (2003). Critical Role of RelB Serine 368 for Dimerization and p100 Stabilization. Journal of Biological Chemistry. 278(40). 39242–39250. 49 indexed citations
19.
Maier, Harald J., et al.. (1986). [Well-differentiated liposarcoma of the submandibular region. Case report and literature review].. PubMed. 65(4). 230–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026